[go: up one dir, main page]

WO1996033723A3 - Use of benzamide derivatives for treating and/or preventing meniere's syndrome and motion sickness - Google Patents

Use of benzamide derivatives for treating and/or preventing meniere's syndrome and motion sickness Download PDF

Info

Publication number
WO1996033723A3
WO1996033723A3 PCT/JP1996/001112 JP9601112W WO9633723A3 WO 1996033723 A3 WO1996033723 A3 WO 1996033723A3 JP 9601112 W JP9601112 W JP 9601112W WO 9633723 A3 WO9633723 A3 WO 9633723A3
Authority
WO
WIPO (PCT)
Prior art keywords
meniere
syndrome
treating
preventing
motion sickness
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP1996/001112
Other languages
French (fr)
Other versions
WO1996033723A2 (en
Inventor
Masayuki Ishie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to JP8524148A priority Critical patent/JPH11503721A/en
Publication of WO1996033723A2 publication Critical patent/WO1996033723A2/en
Publication of WO1996033723A3 publication Critical patent/WO1996033723A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

This invention relates to use of a compound of formula (I) wherein each symbol is as defined in the description, or its pharmaceutically accpetable salt, for treating and/or preventing Meniere's syndrome or motion sickness.
PCT/JP1996/001112 1995-04-28 1996-04-24 Use of benzamide derivatives for treating and/or preventing meniere's syndrome and motion sickness Ceased WO1996033723A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8524148A JPH11503721A (en) 1995-04-28 1996-04-24 New uses of benzamide derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9508637.7 1995-04-28
GBGB9508637.7A GB9508637D0 (en) 1995-04-28 1995-04-28 New use

Publications (2)

Publication Number Publication Date
WO1996033723A2 WO1996033723A2 (en) 1996-10-31
WO1996033723A3 true WO1996033723A3 (en) 1997-01-30

Family

ID=10773666

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1996/001112 Ceased WO1996033723A2 (en) 1995-04-28 1996-04-24 Use of benzamide derivatives for treating and/or preventing meniere's syndrome and motion sickness

Country Status (3)

Country Link
JP (1) JPH11503721A (en)
GB (1) GB9508637D0 (en)
WO (1) WO1996033723A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351709B2 (en) 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
US9096546B2 (en) 2007-05-10 2015-08-04 Albany Molecular Research, Inc. Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
EP2520561B1 (en) 2007-06-08 2016-02-10 MannKind Corporation IRE-1A Inhibitors
RU2720237C2 (en) 2013-11-18 2020-04-28 Форма Терапеутикс, Инк. Compositions containing benzopiperazine as bromodomain bet inhibitors
PT3071203T (en) 2013-11-18 2021-03-11 Forma Therapeutics Inc Tetrahydroquinoline compositions as bet bromodomain inhibitors

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0620216A1 (en) * 1993-04-13 1994-10-19 Fujisawa Pharmaceutical Co., Ltd. Benzamide derivatives and their use as vasopressin antagonists

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0620216A1 (en) * 1993-04-13 1994-10-19 Fujisawa Pharmaceutical Co., Ltd. Benzamide derivatives and their use as vasopressin antagonists

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
A. KAKIGI ET AL.: "Antiduretic hormone (ADH) in patients with Meniere's disease.", EQUILIB. RES. SUPPL., no. 10, 1994, pages 91 - 94, XP000612759 *
L. NAFTALIN ET AL.: "The possible role of hormones and enzymes in the production of the acute attack in Meniere's disease.", EUR. ARCH. OTO-RHINO-LARINGOL., vol. 251, no. 3, pages 173 - 177, XP000612747 *
T. TAKEDA ET AL.: "Plasma antidiuretic hormone in patients with delayed endolymphatic hydrops.", EQUILIB. RES. SUPPL., no. 10, 1994, pages 95 - 100, XP000612758 *

Also Published As

Publication number Publication date
JPH11503721A (en) 1999-03-30
WO1996033723A2 (en) 1996-10-31
GB9508637D0 (en) 1995-06-14

Similar Documents

Publication Publication Date Title
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
EP0423714A3 (en) Hair revitalizing agent
IL132107A0 (en) Substituted phenyl derivatives their preparation and use
WO2001066564A3 (en) Gamma-secretase inhibitors
CA2132098A1 (en) Antimicrobial imidazoles for regulating the greasiness of the skin
EP0828485A4 (en) Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
PL323152A1 (en) Derivatives of 1,3-propanodiole as biologically active compounds
CA2210258A1 (en) Substituted oxazolidine calpain and/or cathepsin b inhibitors
WO2002000209A3 (en) Gabapentin analogues for sleep disorders
SE9603669D0 (en) New combination
EP0990648A4 (en) 4-quinolinol derivatives and agrohorticultural bactericides containing the same as active ingredient
CA2183315A1 (en) Novel Mercaptoacetylamido 1,3,4,5-Tetrahydro-Benzo[c]azepin-3-One Disulfide Derivatives Useful as Inhibitors of Enkephalinase and Ace
IL117656A (en) Pharmaceutical compositions comprising a supported saccharide for the treatment of travellers' diarrhea caused by E.coli LT enterotoxin
HU9700060D0 (en) New compound, it's production and it's use as active component of a medicine
WO1996033723A3 (en) Use of benzamide derivatives for treating and/or preventing meniere's syndrome and motion sickness
CA2364258A1 (en) 3-cyclopropylmethoxy-4-difluoromethoxy-n-(3,5-dichloropyrid-4-yl)benzamide in the treatment of multiple sclerosis
CA2353205A1 (en) Agent for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
AU2003263978A1 (en) 2',3'-dideoxynucleoside analogues for the treatment or prevention of flavivitridae infections
GB9513750D0 (en) Use of allylamines
AU2149797A (en) Therapeutic agents for asthma
WO2000002877A3 (en) New pharmaceutically active compounds
UA29461C2 (en) An agent for treatment of amyloidosis, a method for treatment of amyloidosis
CA2179634A1 (en) 4-arylisoindole analgesics
HU9502509D0 (en) Use of 1,4-dihydropyridine-3,5-dicarboxylic-acid-esters as active component of pharmaceutical compositions

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref country code: JP

Ref document number: 1996 524148

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase